Showing results (241-250 of 3,316) with videos related to
Sort By:
Pageof 332
Journal of Clinical Psychopharmacology|February 1, 1997
The effects of clozapine on symptom clusters in treatment-refractory patientsG Abraham, C Nair, J I Tracy, et al.Journal of Clinical Psychopharmacology|February 1, 1995
Positron emission tomography studies on D2 and 5-HT2 receptor binding in risperidone-treated schizophrenic patientsL Farde, S Nyberg, G Oxenstierna, et al.Journal of Clinical Psychopharmacology|February 1, 1995
Randomized, double-blind, controlled trial of risperidone versus clozapine in patients with chronic schizophreniaE Klieser, E Lehmann, E Kinzler, et al.Journal of Clinical Psychopharmacology|December 1, 1995
Coadministration of nefazodone and benzodiazepines: IV. A pharmacokinetic interaction study with lorazepamD S Greene, D E Salazar, R C Dockens, et al.Journal of Clinical Psychopharmacology|December 1, 1995
Predicting response to fluoxetine in geriatric patients with major depressionL M Koran, S H Hamilton, M Hertzman, et al.Journal of Clinical Psychopharmacology|December 1, 1995
Dosing of antidepressants--the unknown artM JerlingJournal of Clinical Psychopharmacology|April 1, 1996
Fluvoxamine versus clomipramine for obsessive-compulsive disorder: a double-blind comparisonL M Koran, S L McElroy, J R Davidson, et al.Journal of Clinical Psychopharmacology|April 1, 1996
Adverse events and tolerability of the combination of fluoxetine/lithium compared with fluoxetineM Bauer, M Linden, B Schaaf, et al.Journal of Clinical Psychopharmacology|April 1, 1996
Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteersC R Rush, R R GriffithsJournal of Clinical Psychopharmacology|April 1, 1996
ICI 204,636, an atypical antipsychotic: efficacy and safety in a multicenter, placebo-controlled trial in patients with schizophrenia. U.S. SEROQUEL Study GroupR L Borison, L A Arvanitis, B G MillerPageof 332